SPOTLIGHT -
Positive Signs From Prasinezumab in Parkinson Disease: Gennero Pagano, MD, MSc, PhD
The expert medical director at Roche provided detail on results from the phase 2 PASADENA study presented at the 2021 MDS Virtual Congress. [WATCH TIME: 3 minutes]